how many people are on tirzepatide did not impact metabolic adaptation in with obesity, but increased fat oxidation Mounjaro, Zepbound Lowers Risk of
Description
So says, anyway, an article in todays Wall Street Journal (see Behind Antismoking Policy, Influence of Drug Industry)

NICE Technology Appraisal (TA875) recommends semaglutide (Wegovy) only for adults with at least one weight-related comorbidity and a BMI 35 kg/m (or 32.5 kg/m for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean backgrounds)

You dont need complicated routines

Possible constipation as gut motility slows

Skeletal muscle transcriptome in healthy aging
